Enanta Pharmaceuticals Inc (ENTA)

[willyw]

IF that were to be the case, they might also have some limited data on the viral kinetics and safety of the 493/530 co-dosing of phase 2B.

For me, I think I would want a completed 12 week co-dosing and SVR-4 or 12 to know what they HAD before committing to the scope of phase 3 trials.

I am wondering it it may be more than 90 days, since 90 days won't even get you phase 2B SVR-4 data, and they may not have yet started dosing on the phase 2a geno-2/3 trial yet.

Just thinking out loud here....